Sharps technology's ceo issues shareholder letter highlighting hungary manufacturing facility expansion plans to increase securegard and sologard product supply and revenue

New york, dec. 05, 2024 (globe newswire) -- sharps technology, inc., (nasdaq: “stss” and “stssw”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, issues a shareholder letter from robert hayes, the company's chief executive officer.
STSS Ratings Summary
STSS Quant Ranking